Mirabegron is a beta adrenergic agonist indicated for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency.
Mirabegron, in combination with the muscarinic antagonist solifenacin succinate, is indicated for the treatment of OAB with symptoms of urge urinary incontinence, urgency, and urinary frequency
Mirabeg ER Tablet (Extended Release) সম্পর্কে বিস্তারিত জেনে নিন এই লিঙ্ক থেকে Mirabeg ER